Australia
Emyria in global partnership with Sapphire Medical Clinics to leverage UK clinical and research expertise
Emyria Ltd’s (ASX:EMD) clinical operations subsidiary, Emerald Clinics, has entered into a global partnership with UK-based Sapphire Medical Clinics.
The partnership will provide a new source of data to bolster Emyria’s growing cannabinoid data platform and allow Emyria to leverage Sapphire’s resources and infrastructure in the UK to provide services to UK patients.
Support clinical service in UK[hhmc]
Emyria managing director Dr Michael Winlo said: “Access to medicinal cannabis in the UK is restricted in similar ways to how access was restricted in Australia a few years ago.
“We know that regulators in Australia and the UK encourage registration of medicinal cannabis and that this requires high-quality clinical evidence.
“This agreement is part of an evolving partnership between our two organisations which will allow us to support a clinical service in the UK while also collecting high quality de-identified clinical evidence that can greatly enhance the utility and value of our E..
-
Tech7 months ago
Search engine startup asks users to be the customer, not the product
-
Europe4 weeks ago
Covid: Flights shut down as EU discusses UK virus threat
-
Health4 weeks ago
Spain ‘to register’ those who refuse to have Covid-19 vaccine
-
Sports4 years ago
Boxing continues to knock itself out with bewildering, incorrect decisions
-
Sports4 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Europe2 months ago
45 arrested across Europe and Brazil as authorities seize ‘record haul’ of cocaine
-
Sports4 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
latest news7 months ago
Creepy technologies invade European post-pandemic workplaces